JAK1 and colorectal carcinoma: To further investigate whether the JAK1/STAT3 pathway is required for SNORA28‐driven CRC cell proliferation and radioresistance, Niclosamide, which is a small‐molecule STAT3 inhibitor,[25] was used to treat CRC cells that stably overexpressed SNORA28.